Business Wire India
  • E-pharmacy model provides digital tracking and traceability of medicines , addresses the problem of counterfeit medicines , unsupervised consumption of antibiotics without prescription, and improves access & affordability of medicines for the patient - Key takeaways from the event 
launch of Self-regulation Code of Conduct  for the E-pharmacy sectorAccessibility,affordabilitylack of awarenesstrackingtraceability of medicinescounterfeit medicines
  1. Processing medicines against Prescription
  1. Restriction of Sensitive habit forming medicines 
  1. Dispensation only from duly licensed pharmacy domiciled in India  E-pharmacy must ensure that the medicines are dispensed through licensed pharmacies only. The E-pharmacy must make reasonable effort to ensure that all the pharmacy partners (before facilitating the sale of any medicines through such pharmacy partners) are duly registered under the Drugs & Cosmetics Act/ Rules. 
  1. Convenient access of medicines E-pharmacy player must make suitable arrangements to ensure that the medicines are packed, transported and delivered in such a way that their integrity, quality, and effectiveness are preserved.
  1. Public health Initiatives of Government of India  E-pharmacy players must partner with Government for any recall of medicines and collect adverse events of medicines (consumer reports) and comply to submit them to National Centre for Pharmacovigilance.
  1. Customer grievances E-pharmacy must ensure that there is a proper mechanism in place to address any queries or grievances that the end-customer may have. E-pharmacy players must appoint an ombudsman commission comprising of reputed members of civil society to address any public grievance. The Ombudsman commission shall be appointed for six months by members of the governing council in consultation with other stakeholders.
About Federation of Indian Chambers of Commerce and Industry (FICCI)